Providing Optimal Rejuvenation to the Periocular Area Using Botulinum Toxin A Neuromodulators and Hyaluronic Acid Dermal Fillers

Plast Surg Nurs. 2019 Oct/Dec;39(4):119-124. doi: 10.1097/PSN.0000000000000279.

Abstract

The periorbital area is the first area of the face to show signs of aging. To provide safe and natural looking rejuvenation of the delicate eyelids, and supporting structures, an advanced understanding of anatomy, ideal facial proportions, and the most effective methods for rejuvenation is discussed. Periocular rejuvenation is particularly challenging due to the intricate and delicate anatomy of the periocular area. To ensure safe and successful outcomes, it is crucial that injectors use a global approach when providing treatments and that they consider soft tissue, vasculature, and bone structure of the periocular region before administering treatments for aesthetic rejuvenation. Neuromodulators, specifically botulinum toxin A (BoNT-A), and hyaluronic acid (HA) dermal fillers are 2 nonsurgical treatments frequently used to address signs of aging in the periocular area. The objective of this article is to review different BoNT-A and HA filler treatments and discuss how these treatments can be used for optimal rejuvenation of the periocular area.

MeSH terms

  • Botulinum Toxins, Type A / administration & dosage
  • Botulinum Toxins, Type A / standards*
  • Botulinum Toxins, Type A / therapeutic use
  • Dermal Fillers / administration & dosage
  • Dermal Fillers / standards*
  • Dermal Fillers / therapeutic use
  • Humans
  • Hyaluronic Acid / administration & dosage
  • Hyaluronic Acid / standards*
  • Hyaluronic Acid / therapeutic use
  • Injections, Intraocular / methods
  • Neurotransmitter Agents / administration & dosage
  • Neurotransmitter Agents / standards
  • Neurotransmitter Agents / therapeutic use
  • Rejuvenation*
  • Skin Aging / drug effects

Substances

  • Dermal Fillers
  • Neurotransmitter Agents
  • Hyaluronic Acid
  • Botulinum Toxins, Type A